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The range of exoproteins and core exoproteome of 14 Staphylococcus aureus isolates representing major lineages
associated with asymptomatic carriage and clinical disease in the UK was identified by MS proteomics using a combined
database incorporating sequences derived from 39 S. aureus genomes. In all, 632 different proteins were identified and, of
these, only 52 (8%) were found in all 14 isolates whereas 144 (23%) were found in just a single isolate. Comparison of the
observed mass of each protein (based on migration by SDS-PAGE) with its predicted mass (based on amino acid
sequence) suggested that 95% of the proteins identified were not subject to any major post-translational modification.
Migration of 5% of the proteins was not as expected: 1% of the proteins migrated at a mass greater than predicted, while
4% appeared to have undergone proteolytic cleavage; these included SsaA2, Aur, SspP, Ebh as well as BlaR1, MecR1,
FsH, OatA and LtaS. Intriguingly, a truncated SasG was produced by a single CC8 USA300-like strain. The analysis
provided evidence of the marked heterogeneity in protein expression by S. aureus in broth, while yielding a core but narrow
common exoproteome.
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Abbreviations: MRSA, meticillin-resistant S. aureus; MSSA, meticillin-susceptible S. aureus; PI, propidium iodide;
ST, sequence type.
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Data Summary
Tables S1–S3 have been deposited in figshare. DOI: http://
dx.doi.org/10.6084/m9.figshare.1566807
Table S4 (text file), non-overlapping combined database
used to identify S. aureus proteins, has been deposited
in figshare. DOI: http://dx.doi.org/10.6084/m9.figshare.
1566710
Genome data from the 14 isolates used are deposited in the
European Nucleotide Archive (http://www.ebi.ac.uk/ena,
accession number PRJEB12240, secondary study accession
number ERP013694).
Introduction
Staphylococcus aureus is a major nosocomial and commu-
nity-acquired pathogen, which is carried asymptomatically
by much of the population in the anterior nares either per-
sistently or intermittently (Vandenbergh & Verbrugh, 1999).Received 6 October 2015; Accepted 11 January 2016
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Often the cause of minor skin infections, it can give rise to
systemic infections affecting the blood, bone, heart or lung
and trigger toxin-mediated disease such as toxic shock
syndrome, while meticillin-resistant S. aureus (MRSA) poses
additional management challenges (Rudkin et al., 2012).
Since publication of the N315 and Mu50 genomes by
Kuroda et al. (2001), the number of sequenced S. aureus gen-
omes has increased rapidly. Currently, about 50 completed
S. aureus genomes have been deposited at NCBI, whilst
over 600 projects are in progress (www.ncbi.nlm.nih.gov/
genome/genomes/154). Data from such whole genome
sequencing projects have demonstrated that there is a high
level of diversity within the species, with variability occur-
ring in approximately 20–30% of the genome (Witney
et al., 2005). Approximately 70% of the genes can be con-
sidered core (present in w95% isolates), while 10–12%
comprise ‘core-variable’ genes that are lineage specific; the
remainder are encoded bymobile genetic elements and com-
prise the variable genome (Lindsay et al., 2006). Although
some virulence genes reside within the core genome, the
vast majority of core genes encode proteins with housekeep-
ing functions. Conversely,most of the variable and core vari-
able genes are involved in the interaction of the bacterium
with its environment, its host or other bacterial cells.
Sibbald et al. (2006)defined the core exoproteomeofS. aureus
as the 58 proteins with predicted Sec-type signal peptides
encoded by genes present in all sequenced S. aureus strains.
While this in silico bioinformatic approach is highly efficient,
it cannot provide data on expression, post-translational
modifications, cleavage and turnover, which may be import-
ant considerations in pathogenesis research or biomarker
studies. Furthermore, as noted by Sibbald et al., and many
others, Sec-secreted proteins are only a subset of the proteins
found in the supernatants of S. aureus cultures (Henderson &
Martin, 2011; Sibbald et al., 2006; Tjalsma et al., 2004). Many
groups have attempted to define the proteome of S. aureus
(Becher et al., 2009; Nandakumar et al., 2005; Ravipaty &
Reilly, 2010; Sibbald et al., 2006; Ziebandt et al., 2010), to
identify vaccine candidates (Glowalla et al., 2009; Vytvytska
et al., 2002), to study virulence factors and their regulators
(Bernardo et al., 2002; Burlak et al., 2007; Kawano et al.,
2001; Nakano et al., 2002; Pocsfalvi et al., 2008; Rogasch
et al., 2006; Ziebandt et al., 2001, 2004), and to study changes
in proteins in response to different conditions such as anaero-
biosis (Fuchs et al., 2007) and glucose starvation (Michalik
et al., 2009).
In this study we set out to determine the core exoproteome
of 14 clinical S. aureus isolates representing the dominant
clinical lineages identified in the UK. Our approach was
not biased towards any particular protein, based on viru-
lence or any other phenomenon, and made no assump-
tions about proteins that would or would not be secreted
by the bacterium. We analysed S. aureus culture super-
natant proteins using a GeLC-MS proteomic approach
and identified the proteins using a database that combined
sequences from 39 S. aureus completed genomes to identify
as many proteins as possible amongst the clinical isolates
studied, in a single proteomic study.
Methods
Bacterial strains and growth conditions. Fourteen
temporally and geographically unrelated isolates of S. aureus
[six meticillin-susceptible S. aureus (MSSA), eight MRSA]
were selected to represent a broad spectrum of disease
and genetic diversity (including 11 different MLST clonal
complexes). Isolates were grown with shaking at 37 uC in
Lysogeny broth (LB), tryptic soy broth, casein hydrolysate-
yeast extract-containing medium, RPMI and RPMI
containing 0.15 mM desferrioxamine (to sequester iron).
Bacterial growth was assessed by measuring OD600 of
appropriately diluted samples of the culture mixture using a
photometer (Biophotometer; Eppendorf) on three separate
occasions in fresh LB.
SDS-PAGE. Proteins were precipitated from 3.5 ml of
filtered (0.22 mm) culture supernatants obtained by
addition of three volumes of 40% trichloroacetic acid in
acetone overnight at 220 uC; the exact volumes were
adjusted based on OD600 measurements to normalize
protein loading on this basis. Protein pellets were washed
twice with acetone, dried, dissolved in 60 ml LDS
electrophoresis sample treatment buffer with 40 mM DTT
and heated at 70 uC for 10 min. Iodoacetamide (200 mM)
was added to 18 ml of the sample and incubated for 20 min
prior to loading onto a 10% Bistris pre-cast gel
(Life Technologies) and separation using MOPS buffer.
Gels were stained for protein with InstantBlue (Expedeon).
Membrane integrity of S. aureus. In total, 5|108 c.f.u.
S. aureus HHS-1, -7, -8 and -9 were stained with a final
concentration of 30 mM propidium iodide (PI) in 500 ml
PBS, incubated protected from light for 5 min and
then analysed on a FACSCalibur flow cytometer (BD
Biosciences). S. aureus was identified by light-scatter
characteristics, and PI fluorescence was measured in the
Impact Statement
Proteins secreted by 14 strains from clinically rel-
evant major lineages of S. aureus were identified
using an unbiased proteomic method that made no
prior assumptions as to the perceived importance,
class or location of exoproteins. Surprisingly, out of
over 600 different proteins found, only 8% were
common to all lineages, underlining the extreme
heterogeneity of the S. aureus exoproteome, with
relevance for both development of microbial
diagnostics and pathogenetic studies in this species.
Intriguingly, the approach simultaneously identified
novel proteolytic events and hitherto unsuspected
truncated proteins that may impact on virulence
and pathogenesis of S. aureus.
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FL2 channel. Heat-treated S. aureus was incubated at 60 uC
for 30 min prior to staining.
Molecular typing/PCR. Typing of spa was carried out as
described previously (Harmsen et al., 2003). MLST clonal
complex assignments were inferred based on spa typing data
and by reference to the spa server (http://spa.ridom.de/mlst.
shtml). Specific sequence types (STs) were assigned
following whole genome sequencing. Selected toxin genes
were screened for by multiplex PCR, including:
enterotoxins A–E and G–J (sea–see and seg–sej), toxic shock
syndrome toxin-1 (tst), exfoliative toxins A, B and D
(eta, etb and etd), and Panton–Valentine leukocidin
(luk-PV), as described previously (Holmes et al., 2005);
sep and ser were detected by genome sequencing.
Characterization of staphylococcal cassette chromosome
mec (SCCmec) elements was carried out on all MRSA
isolates as described by Milheiric¸o et al. (2007). The sasG
gene was amplified by PCR from genomic DNA extracted
from HHS5 using primers 59-GTCAAAGATGGGGCC-39
and 59-CTTTCGATAATCCTGG-39.
Sample preparation for LC-MS/MS. Isolates were
grown in LB until they reached exponential phase (OD600
of 2.0). Supernatant proteins were precipitated, separated
by SDS-PAGE and stained for protein as described above.
Each lane in the gel was cut into 27 rows. The proteins
present in each gel slice were digested with trypsin, and
the resultant peptides were extracted and analysed by
LC-MS/MS as described previously (Zhu et al., 2008).
Protein identification. Identification of the proteins
present in each gel slice was determined from analysis
of the LC-MS/MS data using SEQUEST and a non-
redundant database based on 39 completed S. aureus
genome sequences available on the PATRIC database
(brcdownloads.vbi.vt.edu/patric2/genomes/) as of 28
October 2013. The database comprised 31784 different
protein sequences followed by 20 common contaminants
such as human keratins. The SEQUEST software assigns
protein designations using the first instance in the
database, so the order that the S. aureus FASTA sequences
appear in the database can be of relevance in the listed
output of identified proteins. S. aureus COL protein
sequences were placed first in the reference database,
which was then expanded sequentially by addition of
non-identical protein sequences that occur in the
following strains: NCTC 8325, JH1, MW2, Mu50, N315,
Newman, USA300_FPR3757, MSSA476, MRSA252, JH9,
Mu3, USA300_TCH1516, JKD6008, ED98, TW20, ST398,
04-02981, ED133, JKD6159, HO 5096 0412, RF122,
LGA251, 08BA02176, CA-347, M1, ST228/10388, ST228/
10497, ST228/15532, ST228/18412, 11819-97, 55/2053,
71193, ECT-R 2, M013, MSHR1132, T0131, TCH60 and
VC40. All SEQUEST results were filtered based on peptide
cross correlation scores exceeding 1.5 (single-charged ions),
2.0 (double-charged ions) and 2.5 (triple-charged ions) and
identification of at least two different peptides to a
protein with a probability score v0.01. Using a database
with FASTA sequences from several genomes increased the
chance of correctly assigning a protein designation, but also
introduced the possibility of peptides from a single protein
matching to multiple orthologues and to indicate falsely
the presence of several different proteins. To address this,
non-COL protein identifications were assigned to an
orthologous COL sequence or, in those cases where no
COL orthologue was found, to another suitable reference
sequence. This was achieved by calculating the minimum
Levenstein distance for each non-COL protein identified
amongst all protein sequences in the COL database. Non-
COL protein sequences with less than 20% mismatches
were assigned to the equivalent COL protein. All others
were analysed using BLAST against a representative set of
S. aureus genomes (NCTC 8325, JH1, MW2, Mu50,
Newman, USA300_FPR3757 and MRSA252) and assigned
to their closest orthologue. Where no match was found the
protein retained its original assignment. The program
PSORTb was used to identify the predicted cellular location
for each protein identified (Yu et al., 2010).
Analysis of the migration of proteins following SDS-
PAGE. The theoretical mass of each protein was calculated
from its predicted sequence as occurs in the PATRIC
database without taking into account any known or
assumed modifications. The actual mass deduced from
migration by SDS-PAGE was determined by comparison
with the migration of electrophoretic markers (SeeBlue Plus2
Pre-stained Protein Standard; Life Technologies). For
proteins identified in a single row the migration position was
taken as the centre of the excised row. For those proteins that
occurred in multiple contiguous rows, the migration
position was estimated as a weighted average based on the
frequency of occurrence of the protein in the different isolates.
Results
Characterization of the exoproteome of 14
S. aureus isolates
The molecular characterization of the study isolates is shown
in Table 1. Isolate HHS-1 was grown in five different media
and the proteins present in each of the supernatants were ana-
lysed by SDS-PAGE (Fig. 1a). Although there was some vari-
ation in the overall intensity of staining, the composition of
the proteins appeared similar in each case. The result obtained
using LB appeared representative and so was selected for use
in further studies. Growth characteristics in LB were exam-
ined for all the isolates. Each isolate grew rapidly in culture
after a short lag phase until an OD600 of approximately 5
was reached when growth slowed (Fig. 1b, and Fig. S1, avail-
able in the online Supplementary Material). The integrity of
the bacterial membrane was assessed in four strains by
measuring the proportion of cells capable of excluding PI.
When cultured to exponential phase (OD600 of 2.0), 99% of
the bacteria excluded PI (isolates HSS-1, HHS-7 and
HSS-8) with the exception of HSS-9, where 95% of the
Exoproteome of clinically relevant S. aureus
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bacteria excluded PI. Bacterial cell membrane integrity was
reduced further after culturing overnight (OD600 ofw6) to
93–99%, whilst heat treatment of the bacteria for 30 min
resulted in substantial loss of ability to exclude PI (*5% in
each case) (Fig. 1c). Thus, culturing the bacteria to exponen-
tial phase growth (OD600 of 2.0) appeared appropriate
for studies of proteins released by viable cells into the
supernatant.
All 14 isolates were cultured to exponential phase (OD600 of
2.0) in LB, and SDS-PAGE of proteins present in each of the
culture supernatants was performed (Fig. 2). This showed
that although it was evident that some bands occurred in
Table 1. Characteristics of the 14 S. aureus isolates studied
-, Not applicable; ST, sequence type derived in silico from genome data.
Strain Year of
isolation
Clinical presentation Toxin gene profile SCCmec
type
spa
type
MLST clonal
complex
ST
HHS-1 2006 Bacteraemia sea, seh IVNT t127 1 1
HHS-2 2005 Skin abscess sed, seg, sei, sej, sep, ser, luk-PV IVc t002 5 5
HHS-3 2009 Skin abscess sed, seg, sei, sej, ser VI t002 5 5
HHS-4 2009 Burn 2* III t037 8 239
HHS-5 2004 Skin abscess luk-PV IVa t008 8 8
HHS-6 2007 Scalded skin syndrome seg, sei, eta 2 t209 9 109
HHS-7 2006 Bacteraemia sec, sep 2 t156 12 1460
HHS-8 2006 Bacteraemia 2* 2 t084 15 15
HHS-9 2006 Bacteraemia sec, seg, sei IVh t032 22 22
HHS-10 2008 Necrotizing pneumonia seg, sei, etd, luk-PV 2 t660 25 25
HHS-11 2006 Bacteraemia sea, seg, sei, tst II t018 30 36
HHS-12 2006 Bacteraemia seg, sei, luk-PV IVc t019 30 30
HHS-13 2007 Skin abscess seg, sei 2 t015 45 45
HHS-14 2007 Scalded skin syndrome seg, sei, eta 2 t171 121(51) 1693
* Specified toxin genes not detected.
Fig. 1. Investigation of culture conditions suitable for proteomic analysis. (a) SDS-PAGE analysis of S. aureus isolate HHS-1 cell-free
supernatant after culture in LB, tryptic soy broth (TSY), casein hydrolysate-yeast extract-containing (CCY) medium, RPMI and RPMI con-
taining desferrioxamine (RPMI-Fe). Supernatant proteins were precipitated and amounts equivalent to a volume of cells with an OD600 of
1.0 were loaded onto the gel. (b) Growth curves showing OD600 over time for all 14 S. aureus isolates, HHS-1 to HHS-14, in LB; error
bars represent SEM of three separate LB cultures on different days. (c) Membrane integrity of S. aureus isolates HHS-1, -7, -8 and -9
determined by exclusion of PI, measured by flow cytometry, cultured to exponential growth phase, OD600 of 2.0 (OD 2), overnight (O/N)
and heat-treated (H/T).
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most of or all the supernatant samples, there was also a high
degree of variation in both the intensity and the distribution
of many individual bands noted (Table 1).
Proteomics was performed on individual gel slices to ident-
ify proteins migrating throughout the gel, and the respect-
ive mass at which proteins migrated. In all, 632 different
proteins were identified amongst the 14 study isolates
(Tables S1–S3). Of these, it was possible to assign 569
(90%) to COL protein sequences using the merged data-
base of 39 genomes (Table S4). The remaining non-COL
proteins were mainly linked to mobile genetic elements.
The program PSORTb was used to predict a cellular location
for each exoprotein identified with the following results:
5% cell wall, 8% cytoplasmic membrane, 64% cytoplasmic,
10% extracellular and 13% unknown.
Distribution of proteins amongst the isolates
Of the 632 proteins identified, just 52 (8%) were identified
in all 14 isolates (Fig. 3, Table 2). Seventeen additional pro-
teins (just 11% of the 632), including gamma-haemolysin
components A and B and staphyloxanthin biosynthesis
protein, were identified in 13/14 of the isolates. Overall,
there appeared to be no threshold fraction that suggested
that a proportion of the isolates might have a common
proteome, regardless of lineage. In fact, the largest group
comprised 144 (23%) proteins that were detected in
just a single isolate, thus demonstrating the extent of
inter-isolate heterogeneity (Fig. 3). Interestingly, one
Panton–Valentine leukocidin-positive strain, HHS-2,
produced the lowest number of detectable exoproteins in
total. This strain also produced the full range of recognized
S. aureus exo-proteases (aureolysin; SspA/V8; SspB/stapho-
pain B; ScpA/staphopain A; SplA–F). In contrast, none of
the classical exo-proteases was detected from HHS-6, a
strain that produced the greatest number of detected
exoproteins.
Evidence of post-translational modifications
As the supernatant proteins were first separated by SDS-
PAGE prior to proteomic identification, it was possible
to estimate approximate masses from their migration and
to compare these values with those expected from the pre-
dicted sequences. A plot of these data showed that 95%
of the proteins identified migrated as expected (Fig. 4).
However, about 1% of the proteins did not migrate as
far through the gel as expected and hence appeared to
have a larger mass than predicted from their sequence.
These included serine-aspartate repeat-containing protein
C (SdrC), clumping factors A and B (ClfA, ClfB), putative
surface anchored protein (SasF), SAAG_00319 (fibronectin
binding protein B), SaurJH1_2050 (phi13 family phage
major tail protein), SAV1826 (enterotoxin, Yent2) and
several hypothetical proteins. The remaining 4% of the
proteins identified migrated faster than expected, i.e. they
appeared to have smaller masses than predicted. Particu-
larly marked differences were apparent for LtaS, OatA,
BlaR1, MecR1, EbpS and FtsH (Fig. 4). Several proteins
Fig. 3. Percentage distribution of S. aureus proteins amongst the
isolates studied. The occurrence of every protein identified in each
of the 14 strains studied was assessed and presented as percen-
tages of the number of proteins found in just one strain (i.e. unique
occurrence) or common to between two and 14 strains, with 14
indicating that the proteins were found in all strains studied.
Fig. 2. SDS-PAGE of proteins present in the supernatant of 14
S. aureus study isolates cultured in LB for proteomic analysis.
Supernatant proteins from each of the culture isolates were pre-
cipitated and amounts equivalent to a volume of cells in exponen-
tial phase growth with an OD600 of 2.0 were loaded onto the gel.
Arrows indicate approximate positions where gel was sliced into
27 rows. Lane M, marker; lanes 1–14, isolates HHS-1 to
HHS-14, respectively.
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Table 2. Proteins common to all 14 S. aureus strains
Of the proteins identified, 52 occurred in all 14 isolates examined. It was possible to assign each protein to a COL sequence as indicated. The program
PSORTb was used to determine the predicted cellular location (C, cytoplasmic; CM, cell membrane; CW, cell wall; E, exoprotein; U, unknown).
Reference S. aureus protein name Predicted location
SACOL0204 Formate acetyltransferase C
SACOL0222 L-Lactate dehydrogenase C
SACOL0452 Alkyl hydroperoxide reductase subunit C C
SACOL0460 Inosine-59-monophosphate dehydrogenase C
SACOL0593 Elongation factor G C
SACOL0594 Elongation factor Tu C
SACOL0660 Alcohol dehydrogenase C
SACOL0838 Glyceraldehyde 3-phosphate dehydrogenase C
SACOL0839 Phosphoglycerate kinase C
SACOL0842 Phosphopyruvate hydratase C
SACOL1092 Phosphoenolpyruvate-protein phosphotransferase C
SACOL1102 Pyruvate dehydrogenase complex E1 component, alpha subunit C
SACOL1104 Branched-chain alpha-keto acid dehydrogenase
subunit E2 C
SACOL1105 Dihydrolipoamide dehydrogenase C
SACOL1329 Glutamine synthetase FemC C
SACOL1516 30S ribosomal protein S1 C
SACOL1637 Molecular chaperone DnaK C
SACOL1722 Trigger factor C
SACOL1729 Threonyl-tRNA synthetase C
SACOL1745 Pyruvate kinase C
SACOL1952 Ferritins family protein C
SACOL2145 Glucosamine-fructose-6-phosphate aminotransferase C
SACOL2213 DNA-directed RNA polymerase subunit alpha C
SACOL2618 L-Lactate dehydrogenase C
SACOL0545 50S ribosomal protein L25/general stress protein Ctc C
SACOL2117 Fructose-bisphosphate aldolase C
SACOL2224 50S ribosomal protein L6 C
SACOL2227 50S ribosomal protein L5 C
SACOL0778 Sulfatase family protein CM
SACOL2002 Map protein, programmed frameshift CM
SACOL0095 Immunoglobulin G binding protein A precursor CW
SACOL0507 LysM domain-containing protein CW
SACOL0609 sdrD protein CW
SACOL0723 LysM domain-containing protein CW
SACOL0856 Clumping factor A CW
SACOL0317/0390 Lipase precursor, interruption-N E
SACOL0860 Thermonuclease precursor E
SACOL1062 Bifunctional autolysin E
SACOL1173 Alpha-haemolysin precursor E
SACOL2004 Leukocidin subunit precursor, putative E
SACOL2006 Aerolysin/leukocidin family protein E
SACOL2291 Staphyloxanthin biosynthesis protein E
SACOL2421 Gamma haemolysin, component C E
SACOL2584 Immunodominant antigen A E
SACOL2660 Immunodominant antigen B E
SACOL2666 N-Acetylmuramoyl-L-alanine amidase E
SACOL2694 Lipase E
SACOL1377 Transketolase U
SACOL0962 Glycerophosphoryl diester phosphodiesterase GlpQ, putative U
SACOL0303 59-Nucleotidase U
SACOL1704 Rod shape-determining protein MreC U
SACOL2418 IgG-binding protein SBI U
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were found to be represented as two or more different
masses, including SsaA2, Aur, SspP and extracellular
matrix-binding protein (Ebh) (SACOL1472). Such
migration is consistent with proteolytic cleavage.
To investigate this further, the distribution of the peptides
detected within the protein sequences was examined and,
in 11 cases, there was sufficient peptide information to
be informative (Fig. 5). For LtaS, OatA, BlaR1, MecR1
and EbpS, the peptides were located in the C-terminal
region of each protein (Fig. 5) suggesting a post-trans-
lational cleavage of the N terminus in each case. SsaA2
appeared to be present as both a full-length protein and
a cleaved product of*15 kDa in all 14 isolates. Unusually,
amongst all the peptides identified, one peptide was only
detected in the cleaved product (12/14 isolates) but was
not detected in the uncleaved precursor (all 14 isolates).
Peptides corresponding to Phi77 ORF006-like protein
were located together in a region that corresponds to a
protein mass of 32 kDa, as observed. Aur was detected as
both a 43 and 25 kDa form. The 43 kDa form contained
peptides from the C-terminal region only whereas the
25 kDa form contained peptides only located in the
N-terminal region of the protein.
SasGwas found in three isolateswhere itmigrated according to
its predictedmass of 136 kDa, although in strain HHS-5 it ran
as a 49 kDa protein, identified from peptides occurring in the
N-terminal region only (Fig. 5H). Thismight be explained by a
nucleotide deletion at nucleotide 1287 of sasG, which is known
to occur in several clinical isolates although a truncated protein
has not previously been identified (Diep et al., 2006; Geoghe-
gan et al., 2010).Consequently, PCRamplificationand sequen-
cing of the central region of the sasG gene from isolate HHS-5
was undertaken. Comparison of the sequence data with the
COL genome showed a single nucleotide deletion 100 nt
downstream of the 59 primer (COL: AAAAAAAGTT; HHS-
5: AAAAAA-GTT) resulting in a premature stop codon.
Fig. 4. Comparison between the masses of S. aureus proteins predicted from amino acid sequences and masses observed from protein
migration in SDS-PAGE. Proteins were identified in 1–14 of the S. aureus isolates studied; those identified to migrate at the mass
predicted from amino acid sequences are plotted along the line of equivalence. Proteins to the left of the line were identified at masses
greater than those predicted from the database. Proteins to the right of the line were identified at masses lower than those predicted and
represent potential cleavage events or truncations. Data points have been overlaid such that those proteins found in the greater number of
isolates are placed in the foreground. Proteins are labelled as SACOL-matching proteins or, where there is no match in COL, to another
suitable reference database. Those proteins discussed in the text and referred to by short name codes are indicated as such and
highlighted in pink.
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Discussion
The present study set out to characterize the exoproteome of
representatives of dominant clones of S. aureus that occur in
the UK, specifically to identify common core exoproteins.
However, despite 70% of S. aureus genes being considered
to belong to the core genome, only 8% of the proteins
detected were shared among these clinically relevant strains.
Furthermore, some 60% of the proteins identified were not
‘professional’ exoproteins, but were of predicted cytosolic
andmetabolic origin. Finally, itwas possible to clearly identify
cleaved and truncated protein products simply from proteo-
mic comparison of observed and expected molecular masses.
Fig. 5. Structural characteristics and location of tryptic peptides of S. aureus proteins that migrated with lower than expected masses
amongst the 14 isolates studied. Predicted trypsin cleavage sites (vertical bars) were determined using ExPASy cutter and those peptides
detected by proteomics are shaded. Arrows indicate the position of known or predicted sites of proteolytic processing of the proteins. Trans-
membrane helices (predicted using the TMHMM server; http://www.cbs.dtu.dk/services/TMHMM/) are represented by dotted lines and filled
circles. Known conserved domains and shown. SP, signal peptide. (A) LtaS (predicted mass: 74 kDa). Peptides corresponding to
the C-terminal end only were identified in the gel region corresponding to a mass of ,49 kDa in all 14 isolates examined. (B)
OatA (predicted mass: 69 kDa). Peptides corresponding to the C-terminal end were identified in the ,30 kDa gel region in isolates HHS-7,
-11, -13 and -14. (C) BlaR1 (predicted mass: 69 kDa). Peptides corresponding to the C-terminal end were identified at ,32 kDa in isolates
HHS-2, -3, -4, -5, -8, -10 and -12. (D) MecR1 (predicted mass: 68 kDa). Peptides corresponding to the C-terminal end were identified
at ,32 kDa in isolates HHS-4 and -11. (E) EbpS (predicted mass: 53 kDa). Peptides corresponding to the C-terminal end were identified
at ,25 kDa in isolates HHS-1, -3, -5 and -13. (F) FtsH (predicted mass: 78 kDa). Peptides corresponding to the C-terminal end were
identified at ,45 kDa in isolates HHS-9, -10 and -13. (G) Phi077 ORF006-like protein (predicted mass: 42 kDa). Peptides corresponding
to the central region of the protein were identified at ,32 kDa in isolates HHS-4, -6, -9 and -11. (H) Aur (predicted mass: 56 kDa).
Peptides were located in two regions: in one (i) at ,40 kDa peptides corresponding to the C-terminal end were identified in isolates
HHS-2, -4, -12 and -13, whereas in the other (ii) at ,25 kDa peptides corresponding to the N terminus were found in isolates HHS-12 and
-13. (I) SsaA2 (predicted mass: 30 kDa). Peptides were identified in all 14 isolates in two gel regions at (i) ,30 kDa and (ii) ,15 kDa.
(J) SasG (predicted mass: 136 kDa). Peptides were identified in two gel regions at (i) ,140 kDa in isolates HHS-1, -3 and -8 and
(ii) ,36 kDa in isolate HHS-5.*Position of premature stop codon in SasG gene.
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Previous studies have identified up to 250 different exo-
proteins in S. aureus culture supernatants (Burlak et al.,
2007; Pocsfalvi et al., 2008), while, in this present analysis
we found a total of 632 proteins, with over 400 in some
individual strains. The greater number of proteins ident-
ified is likely to result from the number of strains evalu-
ated, use of a more sensitive 1D in-gel analytical
technique, and the use of a non-repetitive database of
manageable size that aimed to link each identified protein
to a single reference strain only. The result of the analysis
performed in this way is inclusive, as it is not based on
comparison with any one genome/predicted proteome
and is easier to interpret as it is referenced principally
to one proteome. In this case, we chose to use S. aureus
COL as the reference database, as the characteristics of
this strain are well documented, but the whole process
could just as easily be based on any suitable reference
database. As the approach makes comparisons between
the protein sequences, difficulties with inconsistent or
incorrect annotations that occur between sequence data-
bases are avoided.
Overall, there was considerable heterogeneity between the
proteins identified amongst the 14 isolates analysed in
this study, as has been reported previously for S. aureus
(Ziebandt et al., 2010). The clinical strains were selected
to be representative of UK clinical isolates and to be geneti-
cally diverse, as confirmed by subsequent whole genome
sequencing (Fig. S2). Although the proteomic study was
conducted once only, there were no apparent lineage-
specific features in the proteins identified, apart from
genes that are variably present.
While Ziebandt et al. (2010) reported just seven Sec-
dependent extracellular proteins in 17 clonally different
strains that they examined, our study identified 52 core
extracellular proteins, although several proteins reported
therein were also identified in our study incuding IsaA.
Of the 52 common proteins detected in the current
study, PSORTb predicted a cytoplasmic localization for 28
of them. The appearance of cytoplasmic proteins is
common in studies of the secretome (Ebner et al., 2015;
Foulston et al., 2014; Henderson & Martin, 2011; Sibbald
et al., 2006; Tjalsma et al., 2004). Release of cytosolic pro-
teins could be related to S. aureus production of membrane
vesicles or other specific efflux mechanisms (Ebner et al.,
2015; Lee et al., 2009), although the activity of bifunctional
autolysin (Atl) and amidase (SACOL2666), which were
detected in all strains, and the necessary process of cell-
wall remodelling during growth cannot be discounted.
Post-translational modification of several proteins was
apparent, as evident from aberrant migration or the
appearance of multiple bands following SDS-PAGE.
Some of these proteins migrated more slowly than esti-
mated from their predicted structure, suggesting a greater
mass than expected. Several of these proteins, including
serine-aspartate repeat-containing protein C (SdrC),
clumping factors A and B (ClfA, ClfB), and putative
surface anchored protein (SasF), are known, or presumed,
to be post-translationally modified through a covalent
anchor to the peptidoglycan of the cell-wall envelope,
which would explain their increased mass. The other out-
liers include SAAG_00319 (fibronectin binding protein B),
SaurJH1_2050 (phi13 family phage major tail protein),
SAV1826 (enterotoxin, Yent2) and several hypothetical
proteins for which amino acid composition or multimeri-
zation may explain aberrant migration.
A greater number of proteins was found that migrated
more rapidly than estimated from their amino acid struc-
ture. Some were evident in multiple rows, suggesting pro-
teolysis resulting in cleavage products with smaller masses
compared with the parent proteins. The majority of rapidly
migrating proteins represented known mature products
that had resulted from defined proteolytic processes
rather than as the result of unspecific proteolytic digestion
as might occur if the cells were extensively lysed, underlin-
ing the value of comparing actual and predicted molecular
size when undertaking proteomic studies. There is evidence
from several previous studies to support the assertion of
N-terminal cleavage of LtaS (Gatlin et al., 2006; Gru¨ndling
& Schneewind, 2007; Wo¨rmann et al., 2011), OatA (Schal-
lenberger et al., 2012), BlaR1 (Llarrull et al., 2011; Powers
et al., 2011; Zhang et al., 2001), EbpS (Downer et al., 2002;
Nakakido et al., 2007; Park et al., 1991, 1996), FtsH
(Akiyama, 1999; Karnataki et al., 2009; Krzywda et al.,
2002) and Phi77 ORF006-like protein (Conway et al.,
1995; Duda et al., 1995). Similarly, Aur is known to
undergo sequential processing resulting in two mature
products (Nickerson et al., 2008). SsaA2 was found to be
present as both a full-length protein and an N-terminally
cleaved product of *15 kDa in all 14 isolates. To our
knowledge, this does not appear to have been described
previously, demonstrating the added value of molecular
size comparisons in proteomic studies.
The surface protein SasG was found in the culture super-
natant of just three isolates, where it migrated according
to its predicted mass of 136 kDa. In HHS-5, however,
which represents a USA300-like CC8 lineage, the gene
exhibits a premature stop codon. Accordingly, SasG ran
as a 49 kDa protein, identified from peptides occurring
in the N-terminal region only, corresponding to the A
domain of a truncated SasG. To our knowledge, this is
the first evidence that the A domain is expressed, secreted
and stable enough to be detected when SasG is truncated.
Studies point to a role of SasG in S. aureus biofilm for-
mation, attributed largely to the bacterial cell-wall-bound
B domain of the protein (Corrigan et al., 2007; Roche
et al., 2003). Although a specific role for soluble A
domain has yet to be proven, the finding may be of
importance given that recombinant A domain can contrib-
ute to auto-aggregation through homo-oligomerization
(Kuroda et al., 2008).
Identification of the core exoproteins produced in broth
that are common to clinically relevant S. aureus lineages
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may provide potential immunodiagnostic biomarkers of
S. aureus growth, for example in blood cultures, where
rapid distinction from coagulase-negative staphylococci
would be advantageous. Biomarkers could include those
with housekeeping functions, provided that there is no
orthologue in other staphylococci, or provided that the
C-terminal sequence is unique, making them suitable tar-
gets for C-terminal antibody-based diagnostics (Edwards
et al., 2007). Potential candidates include alcohol dehydro-
genase, both lactate dehydrogenases and staphylococcal
immunodominant antigen A (IsaA), although these find-
ings cannot be extrapolated to clinical samples produced
in vivo without further experimentation.
In conclusion, we have determined the experimental exo-
proteome of the important human pathogen S. aureus in
14 genetically diverse, clinically relevant isolates of the
species. As well as identifying the presence of a variety of
functionally relevant proteins we have also used this large
dataset to reveal information concerning protein proces-
sing and truncation of SasG. Our approach was unbiased,
and did not place emphasis on any particular class of pro-
tein, such as virulence factors, nor make assumptions
about which proteins should or should not be found in
the supernatant. Indeed, many proteins found outside
the cell did not have predictable signal sequences and,
whilst they may be products of cell turnover, it is also poss-
ible that they are performing as yet unknown functions on
the surface or outside the cell.
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